Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Change in Receivables (2018 - 2025)

Historic Change in Receivables for Selectis Health (GBCS) over the last 9 years, with Q3 2025 value amounting to $258727.0.

  • Selectis Health's Change in Receivables fell 5386.37% to $258727.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 3273.74%. This contributed to the annual value of $1.6 million for FY2024, which is 13687.16% up from last year.
  • Latest data reveals that Selectis Health reported Change in Receivables of $258727.0 as of Q3 2025, which was down 5386.37% from $303280.0 recorded in Q2 2025.
  • In the past 5 years, Selectis Health's Change in Receivables ranged from a high of $1.3 million in Q2 2022 and a low of -$1.9 million during Q3 2022
  • Its 5-year average for Change in Receivables is $336067.6, with a median of $369977.0 in 2023.
  • Examining YoY changes over the last 5 years, Selectis Health's Change in Receivables showed a top increase of 77062.89% in 2022 and a maximum decrease of 25214.84% in 2022.
  • Selectis Health's Change in Receivables (Quarter) stood at -$62725.0 in 2021, then surged by 770.63% to $420652.0 in 2022, then decreased by 11.82% to $370925.0 in 2023, then soared by 91.56% to $710529.0 in 2024, then plummeted by 63.59% to $258727.0 in 2025.
  • Its Change in Receivables stands at $258727.0 for Q3 2025, versus $303280.0 for Q2 2025 and $358124.0 for Q1 2025.